The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Abstract
A long-standing paradox in cellular immunology concerns the conditional requirement for CD4+ T-helper (T(H)) cells in the priming of cytotoxic CD8+ T lymphocyte (CTL) responses in vivo. Whereas CTL responses against certain viruses can be primed in the absence of CD4+ T cells, others, such as those mediated through 'cross-priming' by host antigen-presenting cells, are dependent on T(H) cells. A clearer understanding of the contribution of T(H) cells to CTL development has been hampered by the fact that most T(H)-independent responses have been demonstrated ex vivo as primary cytotoxic effectors, whereas T(H)-dependent responses generally require secondary in vitro re-stimulation for their detection. Here, we have monitored the primary and secondary responses of T(H)-dependent and T(H)-independent CTLs and find in both cases that CD4+ T cells are dispensable for primary expansion of CD8+ T cells and their differentiation into cytotoxic effectors. However, secondary CTL expansion (that is, a secondary response upon re-encounter with antigen) is wholly dependent on the presence of T(H) cells during, but not after, priming. Our results demonstrate that T-cell help is 'programmed' into CD8+ T cells during priming, conferring on these cells a hallmark of immune response memory: the capacity for functional expansion on re-encounter with antigen.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The latter cell death is mediated by expression of the death ligand TRAIL, which triggers apoptosis in the helpless CTL as well as other activated T cells70,72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“In support of this, TRAIL-deficient mice were resistant to tolerance induction by intravenously injected apoptotic cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“As a result, the CD8+ T cells produce TRAIL upon re-exposure to antigen, which acts to inhibit immunization for cell-mediated responses (that is, mediate tolerance).”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
In the citing paper
“DC that have engulfed necrotic cells present antigen to both CD4+ and CD8+ T cells, however those that engulf apoptotic cells present antigen to CD8+ T cells but not CD4+ T cells72.”
From Immunogenic and tolerogenic cell death (2009) · cites this paper as [72]
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848
T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions
Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., & Melief, C. J. M. (1998) · Nature · doi:10.1038/31002 · Cited by 2,615
Self-citationA conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Ridge, J. P., Rosa, F. D., & Matzinger, P. (1998) · Nature · doi:10.1038/30989 · Cited by 2,360
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,091
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865
Immunological memory and protective immunity: understanding their relation
Ahmed, R., & Gray, D. (1996) · Science · doi:10.1126/science.272.5258.54 · Cited by 1,775 · cited 1×
“Although transition through these stages was thought to be governed by the presence and eventual elimination of antigen, mounting evidence suggests that CD8 p T-cell development is guided by an instructional programme that, once set into motion during priming, is executed independentl”
BackgroundDialynas, D. P., Quan, Z., Wall, K. A., Pierrès, A., Quintáns, J., Loken, M. R., Pierres, M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.131.5.2445 · Cited by 1,273
Kaech, S. M., & Ahmed, R. (2001) · Nature Immunology · doi:10.1038/87720 · Cited by 1,265
van Stipdonk, M. J. B., Lemmens, E. E., & Schoenberger, S. P. (2001) · Nature Immunology · doi:10.1038/87730 · Cited by 843
Self-citationT Cell-Dependent B Cell Activation
Parker, D. C. (1993) · Annual Review of Immunology · doi:10.1146/annurev.iy.11.040193.001555 · Cited by 739
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,000
Veazey, R. S., Acierno, P. M., McEvers, K. J., Baumeister, S. H. C., Foster, G., Rett, M. D., Newberg, M. H., Kuroda, M. J., Williams, K. C., Kim, E., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02748-07 · Cited by 34
Colleton, B. A., Huang, X., Melhem, N. M., Fan, Z., Borowski, L., Rappocciolo, G., & Rinaldo, C. R. (2009) · Journal of Virology · doi:10.1128/jvi.02611-08 · Cited by 34
Puliaev, R., Puliaeva, I., Welniak, L. A., Ryan, A. E., Haas, M., Murphy, W. J., & Via, C. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.47 · Cited by 34
Calzada‐Fraile, D., Iborra, S., Ramírez‐Huesca, M., Jorge, I., Dotta, E., Hernández‐García, E., Martin-Cofreces, N. B., Nistal‐Villán, E., Veiga, E., Vázquez, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42480-3 · Cited by 33
Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy
Jiang, D., Zhang, J.-P., Cheng, L., Zhang, G.-W., Li, Y., Li, Z., Lü, Z., Zhang, Z., Lu, Y., Zheng, L., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.011 · Cited by 33
Yang, Y., Che, Y., Zhao, Y., & Wang, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.01.024 · Cited by 34
Shaping Successful and Unsuccessful CD8 T Cell Responses Following Infection
Cox, M. A., & Zajac, A. J. (2010) · BioMed Research International · doi:10.1155/2010/159152 · Cited by 33
Engaging Natural Killer T Cells as ‘Universal Helpers’ for Vaccination
Speir, M., Hermans, I. F., & Weinkove, R. (2016) · Drugs · doi:10.1007/s40265-016-0675-z · Cited by 33
Ashcraft, K. A., Hunzeker, J., & Bonneau, R. H. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.04.010 · Cited by 33
Rocha, B., & Tanchot, C. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00378.x · Cited by 34
CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells
Johansen, P., Stamou, P., Tascon, R. E., Lowrie, D. B., & Stockinger, B. (2003) · European Journal of Immunology · doi:10.1002/eji.200324231 · Cited by 33
Spectrum of T‐lymphocyte activities regulating allergic lung inflammation
Gelfand, E. W., Joetham, A., Wang, M., Takeda, K., & Schedel, M. (2017) · Immunological Reviews · doi:10.1111/imr.12561 · Cited by 32
Prognostic impact of a tumor-infiltrating lymphocyte subtype in triple negative cancer of the breast
Jamiyan, T., Kuroda, H., Yamaguchi, R., Nakazato, Y., Noda, S., Onozaki, M., Abe, A., & Hayashi, M. (2020) · Breast Cancer · doi:10.1007/s12282-020-01084-1 · Cited by 32
Spira, A. I., Hansen, A. R., Harb, W. A., Curtis, K. K., Koga‐Yamakawa, E., Origuchi, M., Li, Z., Ertik, B., & Shaib, W. L. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00813-6 · Cited by 32
Stock, S., Benmebarek, M.-R., Kluever, A.-K., Darowski, D., Jöst, C., Stubenrauch, K., Benz, J., Freimoser–Grundschober, A., Moessner, E., Umaña, P., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-005054 · Cited by 35
Clinical consequences of circulating CD28-negative T cells for solid organ transplantation
Betjes, M. G. H. (2015) · Transplant International · doi:10.1111/tri.12658 · Cited by 33
Mucosal effector memory T cells: the other side of the coin
Cheroutre, H., & Madakamutil, L. T. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5232-y · Cited by 32
Enhanced CD8 T Cell Responses through GITR-Mediated Costimulation Resolve Chronic Viral Infection
Pascutti, M. F., Geerman, S., Slot, E. M., van Gisbergen, K. P. J. M., Boon, L., Arens, R., van Lier, R. A. W., Wolkers, M. C., & Nolte, M. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004675 · Cited by 32
Current developments with peptide-based human tumor vaccines
Khazaie, K., Bonertz, A., & Beckhove, P. (2009) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328331a78e · Cited by 32
Peripheral tolerance in CD8+ T cells
Srinivasan, M., & Frauwirth, K. A. (2009) · Cytokine · doi:10.1016/j.cyto.2009.01.010 · Cited by 32
Monjazeb, A. M., Tietze, J. K., Grossenbacher, S. K., Hsiao, H., Zamora, A. E., Mirsoian, A., Koehn, B. H., Blazar, B. R., Weiss, J. M., Wiltrout, R. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102709 · Cited by 32
Yousef, S., Planas, R., Chakroun, K., Hoffmeister‐Ullerich, S., Binder, T. M. C., EIERMANN, T. H., Martinꝉ, R., & Sospedra, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201612 · Cited by 32
Bartholdy, C., Kauffmann, S. Ø., Christensen, J. P., & Thomsen, A. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1662 · Cited by 32
Ondondo, B., Yang, H., Dong, T., di Gleria, K., Suttill, A., Conlon, C. P., Brown, D., Williams, P., Rowland‐Jones, S., Hanke, T., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200636508 · Cited by 31
Effective colon cancer prophylaxis in mice using embryonic stem cells and carbon nanotubes
Mocan, T., & Iancu, C. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24060 · Cited by 31
RetractedTranscriptional Programs Underlying Cd4 T Cell Differentiation and Functions
Chalmin, F., Humblin, É., Ghiringhelli, F., & Végran, F. (2018) · International review of cytology · doi:10.1016/bs.ircmb.2018.07.002 · Cited by 33
Krotova, K. Y., Day, A., & Aslanidi, G. (2019) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2019.10.001 · Cited by 31
How Does B Cell Antigen Presentation Affect Memory CD4 T Cell Differentiation and Longevity?
Welsh, R. A., Song, N., & Sadegh‐Nasseri, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.677036 · Cited by 31
Ford, M. L., Wagener, M. E., Hanna, S. S., Pearson, T. C., Kirk, A. D., & Larsen, C. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7203 · Cited by 31
Lepage, S. E., & Lapointe, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2516 · Cited by 31
Giraldo, N. A., Bolaños, N. I., Cuéllar, A., Roa, N. L., Cucunubá, Z. M., Rosas, F., Velasco, V. M., Puerta, C. J., & González, J. M. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002038 · Cited by 31
LTβR and CD40: working together in dendritic cells to optimize immune responses
Gommerman, J. L., & deLuca, L. S. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01056.x · Cited by 31
Effect of the CTL proliferation program on virus dynamics
Wodarz, D., & Thomsen, A. R. (2005) · International Immunology · doi:10.1093/intimm/dxh303 · Cited by 31
Salter, R. D., & Shurin, M. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4 · Cited by 32
Pires, A., Nelson, M. R., Pozniak, A. L., Fisher, M., Gazzard, B., Gotch, F., & Imami, N. (2005) · Journal of Immune Based Therapies and Vaccines · doi:10.1186/1476-8518-3-7 · Cited by 31
Boritz, E., Palmer, B. E., & Wilson, C. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12638-12646.2004 · Cited by 31
Reactive T Cells in Convalescent COVID-19 Patients With Negative SARS-CoV-2 Antibody Serology
Steiner, S., Schwarz, T., Corman, V. M., Sotzny, F., Bauer, S., Drosten, C., Volk, H., Scheibenbogen, C., & Hanitsch, L. G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.687449 · Cited by 29
Nab2 regulates secondary CD8+ T-cell responses through control of TRAIL expression
Wolkers, M. C., Gerlach, C., Arens, R., Janssen, E. M., Fitzgerald, P., Schumacher, T. N., Medema, J. P., Green, D. R., & Schoenberger, S. P. (2011) · Blood · doi:10.1182/blood-2011-08-373910 · Cited by 32
Self-citationCancer Immunoprevention: Current Status and Future Directions
Keshavarz‐Fathi, M., & Rezaei, N. (2021) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-021-00604-x · Cited by 31
Mothé, B. R., Stewart, B. S., Oseroff, C., Bui, H., Stogiera, S., Garcia, Z., Dow, C., Rodriguez‐Carreno, M. P., Kotturi, M. F., Pasquetto, V., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1058 · Cited by 30
Self-citationRyu, S. J., Jung, K. M., Yoo, H. S., Kim, T. W., Kim, S., Chang, J., & Choi, E. Y. (2009) · Blood · doi:10.1182/blood-2008-09-181263 · Cited by 30
Generation and maintenance of human memory cells during viral infection
Halwani, R., Doroudchi, M., Yassine‐Diab, B., Janbazian, L., Shi, Y., Said, E. A., Haddad, E. K., & Sékaly, R. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0027-2 · Cited by 30
Bartlett, E. K., Fetsch, P. A., Filie, A. C., Abati, A. D., Steinberg, S. M., Wunderlich, J. R., White, D. E., Stephens, D. J., Marincola, F. M., Rosenberg, S. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2690 · Cited by 30
Chin’ombe, N., Bourn, W. R., Williamson, A., & Shephard, E. (2009) · Virology Journal · doi:10.1186/1743-422x-6-87 · Cited by 30
Cancer immunotherapy targeting the telomerase reverse transcriptase.
Huo, L.-F., Tang, J. W., Huang, J. J., Huang, P. T., Huang, C. F., Kung, H. F., & Lin, M. C. M. (2006) · PubMed · Cited by 30
Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection
Li, S. X., Barrett, B. S., Guo, K., Kassiotis, G., Hasenkrug, K. J., Dittmer, U., Sutter, K., & Santiago, M. L. (2016) · Scientific Reports · doi:10.1038/srep20425 · Cited by 30
T-cell activation and transplantation tolerance
Priyadharshini, B., Greiner, D. L., & Brehm, M. A. (2011) · Transplantation Reviews · doi:10.1016/j.trre.2011.09.002 · Cited by 30
Sun, Y., Schmitz, J. E., Acierno, P. M., Santra, S., Subbramanian, R. A., Barouch, D. H., Gorgone, D. A., Lifton, M. A., Beaudry, K. R., Manson, K. H., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4753 · Cited by 30
Sun, Y., Permar, S. R., Buzby, A. P., & Letvin, N. L. (2007) · Journal of Virology · doi:10.1128/jvi.00482-07 · Cited by 30
Telomerase-based immunotherapy of cancer
Carpenter, E. L., & Vonderheide, R. H. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.10.1031 · Cited by 30
Telomerase and CD4 T Cell Immunity in Cancer
Dosset, M., Castro, A., Carter, H. K., & Zanetti, M. (2020) · Cancers · doi:10.3390/cancers12061687 · Cited by 33
Imatinib Mesylate Inhibits Antigen-Specific Memory CD8 T Cell Responses In Vivo
Sinai, P., Berg, R. E., Haynie, J. M., Egorin, M. J., Ilaria, R. L., & Forman, J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2028 · Cited by 29
Shameli, A., Yamanouchi, J., Tsai, S. J., Yang, Y., Clemente‐Casares, X., Moore, A. V., Serra, P., & Santamaría, P. (2012) · European Journal of Immunology · doi:10.1002/eji.201242845 · Cited by 29
Wang, M., Tang, S. T., Stryhn, A., Justesen, S. F. L., Larsen, M. V., Dziegiel, M. H., Lewinsohn, D. M., Buus, S., Lund, O., & Claësson, M. H. (2011) · Immunology · doi:10.1111/j.1365-2567.2010.03383.x · Cited by 30
Chimeric Rat/Human HER2 Efficiently Circumvents HER2 Tolerance in Cancer Patients
Occhipinti, S., Sponton, L., Rolla, S., Caorsi, C., Novarino, A., Donadio, M., Bustreo, S., Satolli, M. A., Pecchioni, C., Marchini, C., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2663 · Cited by 29
T-cell immunity generated by recombinant adenovirus vaccines
Yang, T. C., Millar, J., Grinshtein, N., Bassett, J. D., Finn, J. D., & Bramson, J. L. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.347 · Cited by 29
Chiang, C. L.-L., Maier, D. A., Kandalaft, L. E., Brennan, A. L., Lanitis, E., Ye, Q., Levine, B. L., Czerniecki, B. J., Powell, D. J., & Coukos, G. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-198 · Cited by 29
Nakamura, Y., Watchmaker, P. B., Urban, J. A., Sheridan, B. S., Giermasz, A. S., Nishimura, F., Sasaki, K., Cumberland, R. L., Muthuswamy, R., Mailliard, R. B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1735 · Cited by 29
Whitmire, J. K., Benning, N., Eam, B., & Whitton, J. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6777 · Cited by 30
Sage, L. K., Fox, J. M., Mellor, A. L., Tompkins, S. M., & Tripp, R. A. (2014) · Viral Immunology · doi:10.1089/vim.2013.0105 · Cited by 29
Liu, X., He, L., Han, J., Wang, L., Li, M., Jiang, Y., Wang, X., & Yang, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170605 · Cited by 29
Xie, Y., Wu, J., Xu, A., Ahmeqd, S., Sami, A., Chibbar, R., Freywald, A., Zheng, C., & Xiang, J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.01.078 · Cited by 29
Pack, C. D., Kumaraguru, U., Suvas, S., & Rouse, B. T. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.01.152 · Cited by 29
Su, H. C., Chang, D. S., Gambhir, S. S., & Braun, J. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4459 · Cited by 29
The role of T cells in cutaneous autoimmune disease
Chow, S., Rizzo, C., Ravitskiy, L., & Sinha, A. A. (2005) · Autoimmunity · doi:10.1080/08916930500124429 · Cited by 29
Direct Cross-Priming by Th Lymphocytes Generates Memory Cytotoxic T Cell Responses
Kennedy, R. B., Undale, A. H., Kieper, W. C., Block, M. S., Pease, L. R., & Celis, E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.3967 · Cited by 29
The Impact of a Boosting Immunogen on the Differentiation of Secondary Memory CD8 + T Cells
Hovav, A., Panas, M. W., Osuna, C. E., Cayabyab, M. J., Autissier, P., & Letvin, N. L. (2007) · Journal of Virology · doi:10.1128/jvi.01519-07 · Cited by 30
Cell-mediated immune responses induced by BHV-1: rational vaccine design
den Hurk, S. V. D. L. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.369 · Cited by 29
Harrer, T., Plettenberg, A., Arastéh, K., van Lunzen, J., Fätkenheuer, G., Jaeger, H., Janssens, M., Burny, W., Collard, A., Roman, F. P., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.030 · Cited by 28
Rapid Evolution of the CD8+ TCR Repertoire in Neonatal Mice
Carey, A. J., Gracias, D. T., Thayer, J. L., Boesteanu, A. C., Kumova, O. K., Mueller, Y. M., Hope, J. L., Fraietta, J. A., van Zessen, D. B. H., & Katsikis, P. D. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502126 · Cited by 28
Precision T-cell therapy targets tumours
Melief, C. J. M. (2017) · Nature · doi:10.1038/nature23093 · Cited by 28
Jiang, Z., Zhu, L., Cai, Y., Yan, J., Fan, Y., Lv, W., Gong, S., Yin, X., Yang, X., Sun, X., et al. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108886 · Cited by 28
Mirano‐Bascos, D., Tary‐Lehmann, M., & Landry, S. J. (2008) · European Journal of Immunology · doi:10.1002/eji.200738011 · Cited by 28
Doucet, J.-D., Forget, M., Grange, C., Rouxel, R. N., Arbour, N., von Messling, V., & Lapointe, R. (2011) · Journal of General Virology · doi:10.1099/vir.0.029777-0 · Cited by 28
Roetynck, S., Olotu, A., Simam, J., Marsh, K., Stockinger, B., Urban, B. C., & Langhorne, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055195 · Cited by 28
Joshi, P. S., Liu, J.-Q., Wang, Y., Chang, X., Richards, J. O., Assarsson, E., Shi, F., Ljunggren, H., & Bai, X. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0506305 · Cited by 28
Mechanisms of Peptide Vaccination in Mouse Models
van Hall, T., & van der Burg, S. H. (2012) · Advances in immunology · doi:10.1016/b978-0-12-396548-6.00003-2 · Cited by 30
Betts, M. R., Gray, C. M., Cox, J. H., & Ferrari, G. (2006) · Expert Review of Vaccines · doi:10.1586/14760584.5.4.505 · Cited by 28
Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy
Petrovas, C., Mueller, Y. M., & Katsikis, P. D. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401595 · Cited by 28
Subbannayya, Y., Haug, M., Pinto, S. M., Mohanty, V., Meås, H. Z., Flo, T. H., Prasad, T. S. K., & Kandasamy, R. K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010275 · Cited by 29
Chimeric DNA Vaccines: An Effective Way to Overcome Immune Tolerance
Riccardo, F., Bolli, E., Macagno, M., Arigoni, M., Cavallo, F., & Quaglino, E. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_426 · Cited by 28
Srivastava, A. K., Sharma, R. K., Yolcu, E. S., Ulker, V., MacLeod, K. J., Dinc, G., & Shirwan, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048463 · Cited by 27
Wiesch, J. S. Z., Lauer, G. M., Timm, J., Kuntzen, T., Neukamm, M., Berical, A. C., Jones, A. M., Nolan, B. E., Longworth, S., Kasprowicz, V. O., et al. (2007) · Blood · doi:10.1182/blood-2007-01-069583 · Cited by 27
Jing, L., McCaughey, S. M., Davies, D. H., Chong, T. M., Felgner, P. L., Rosa, S. C. D., Wilson, C. B., & Koelle, D. M. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.05.011 · Cited by 27
Côté, A. L., Byrne, K. T., Steinberg, S. M., Zhang, P., & Turk, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026491 · Cited by 29
Zhai, Y., Wang, Y., Wu, Z., & Kupiec‐Weglinski, J. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4529 · Cited by 27
Cavalcanti, E., Gigante, M., Mancini, V., Battaglia, M., Ditonno, P., Capobianco, C., Cincione, R. I., Selvaggi, F. P., Herr, W., Storkus, W. J., et al. (2010) · BioMed Research International · doi:10.1155/2010/935764 · Cited by 27
Wang, F., Yu, T., Zheng, H., & Lao, X. (2018) · Scientific Reports · doi:10.1038/s41598-018-30956-y · Cited by 27
Kim, S.-H., Cho, E., Kim, Y. I., Han, C., Choi, B. K., & Kwon, B. S. (2021) · Nature Communications · doi:10.1038/s41467-021-25559-7 · Cited by 28
Nair, S. R., Zelinskyy, G., Schimmer, S., Gerlach, N., Kassiotis, G., & Dittmer, U. (2009) · Journal of General Virology · doi:10.1099/vir.0.015834-0 · Cited by 28
Simmons, W. J., Koneru, M., Mohindru, M., Thomas, R. M., Cutro, S., Singh, P., DeKruyff, R. H., Inghirami, G., Coyle, A. J., Kim, B., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.3.1405 · Cited by 27
Mallard, E., Vernel-Pauillac, F., Velu, T. J., Lehmann, F. F., Abastado, J., Salcedo, M., & Bercovici, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.6.3963 · Cited by 27
de Herve, M.-G. D. G., Dembelé, B., Vallée, M., Herr, F., Cariou, A., & Taoufik, Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904209 · Cited by 26
Tse, S., Radtke, A. J., & Zavala, F. P. (2011) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762011000900022 · Cited by 26
Panagioti, E., Redeker, A., van Duikeren, S., Franken, K. L. M. C., Drijfhout, J. W., van der Burg, S. H., & Arens, R. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005895 · Cited by 26
van Dinther, D., Veninga, H., Revet, M., Hoogterp, L., Olesek, K., Grabowska, J. A., Borg, E. G. F., Kalay, H., van Kooyk, Y., & den Haan, J. M. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01997 · Cited by 26
Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines
Wiesner, M., Zentz, C., Hammer, M. H., Cobbold, M., Kern, F., Kolb, H., Hammerschmidt, W., Zeidler, R., & Moosmann, A. (2005) · European Journal of Immunology · doi:10.1002/eji.200425936 · Cited by 26
Nair, S., Bayer, W., Ploquin, M. J.-Y., Kassiotis, G., Hasenkrug, K. J., & Dittmer, U. (2011) · Retrovirology · doi:10.1186/1742-4690-8-76 · Cited by 27
Tsang, C.-W., Lin, X., Gudgeon, N. H., Taylor, G. S., Jia, H., Hui, E. P., Chan, A. T. �., Lin, C. K., & Rickinson, A. B. (2006) · Journal of Virology · doi:10.1128/jvi.00400-06 · Cited by 26
Resolution of infection promotes a state of dormancy and long survival of CD4 memory T cells
Dalai, S. K., Khoruzhenko, S., Drake, C. G., Jie, C., & Sadegh‐Nasseri, S. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.2 · Cited by 27
Metadata
- Authors
- Janssen, E. M., Lemmens, E. E., Wolfe, T., Christen, U., von Herrath, M. G., & Schoenberger, S. P.
- Affiliations
- La Jolla Institute for Immunology (US)
- Corresponding author
- Schoenberger, Stephen P.
- Venue
- Nature
- Published
- 2003-02
- Volume
- 421
- Issue
- 6925
- Pages
- 852-856
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1493822493
- Cited by
- 1,635
- References
- 28
- Citations by year
- 2026: 19 · 2025: 24 · 2024: 37 · 2023: 46 · 2022: 37 · 2021: 42 · 2020: 58 · 2019: 42 · 2018: 52 · 2017: 36 · 2016: 41 · 2015: 61 · 2014: 63 · 2013: 63 · 2012: 71
- FWCI
- 46.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- CD4+ T cells, CD8+ T cells, cytotoxic T lymphocytes, T helper cells, secondary immune response, T cell memory, T cell help, cross-priming, antigen-presenting cells, T cell differentiation
- MeSH terms
- Animals, Antigens, Cell Line, Cytotoxicity, Immunologic, Flow Cytometry, T-Lymphocytes, Helper-Inducer, Immunologic Memory, Lymphocyte Activation, Lymphocytic choriomeningitis virus, T-Lymphocytes, Cytotoxic, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review